Cytomegalovirus (CMV) continues to have a tremendous impact in solid organ
transplantation despite remarkable advances in its diagnosis, prevention and treatment. It …

Cytomegalovirus (CMV) continues to be one of the most important pathogens that
universally affect solid organ and allogeneic hematopoietic stem cell transplant recipients …

Background Recommendations of the use of antibody induction treatments in kidney
transplant recipients (KTR) are based on moderate quality and historical studies. This …

In the 30 years since the rabbit antithymocyte globulin (rATG) Thymoglobulin® was first
licensed, its use in solid organ transplantation and hematology has expanded progressively …

Background Antioxidant donor pretreatment is one of the pharmacologic strategy proposed
to prevent renal ischemia-reperfusion injuries and delayed graft function (DGF). The aim of …

Ischemia and reperfusion injury is an inevitable event in renal transplantation. The most
important consequences are delayed graft function, longer length of stay, higher hospital …

Delayed graft function (DGF) is very high in our center (70%‐80%), and we usually receive a
kidney for transplant after more than 22 hours of static cold ischemia time (CIT). Also, there is …

The incidence and outcomes of acute kidney injury (AKI) in kidney transplantation are poorly
known. Retrospective cohort analysis was performed on the data of all patients (≥ 3 months …

Introduction: Sensitization is associated with worse clinical outcomes after kidney
transplantation (KT), including increased incidence of delayed graft function, acute rejection …

In immunocompromised hosts, it may be more difficult to recognize infection as typical signs
and symptoms are not present. Therefore routine monitoring for de novo infection or …